Skip to main content
Top
Published in: Endocrine 2/2017

01-11-2017 | Original Article

Incidence and all-cause mortality for hip fracture in comparison to stroke, and myocardial infarction: a fifteen years population-based longitudinal study

Authors: Vincenzo Carnevale, Andrea Fontana, Alfredo Scillitani, Roberto Sinisi, Elisabetta Romagnoli, Massimiliano Copetti

Published in: Endocrine | Issue 2/2017

Login to get access

Abstract

Purpose

This population-based study investigated the incidence, in-hospital and long-term all-cause mortality, for hip fracture (HipFx), stroke (STR), and myocardial infarction (MI) in residents hospitalized between 2000 and 2014.

Methods

Data about hospitalization were drawn from the administrative discharge database, whereas information about residents and all-cause mortality from the municipality of our town. Patients were followed-up from the first hospital admission until death or study end. For each cause, crude and age-adjusted all-cause mortality of men and women were compared by Mann–Whitney’s test and Poisson models. Separate age-sex adjusted Cox models were estimated and the corresponding adjusted survival curves were drawn.

Results

Among 1292 hospitalizations (of 1109 patients), 434 were for HipFx, 526 for STR, 332 for MI (183 with and 149 without coronary revascularization –MIwCR and MIwoCR, respectively). The incidence of HipFx and STR did not vary over time, MI slightly increasing in men. Age-adjusted in-hospital mortality for HipFx was lower than for STR and MIwoCR in the whole sample and in women (p < 0.001), but not in men. After discharge, men with HipFx had shorter survival and higher crude and age-adjusted mortality rate than women. The estimated HRs(95%CI) in respect to patients with MIwCR (having the lowest mortality) were: 6.11(3.12–11.97), p < 0.001 for HipFx; 5.78(2.93–11.32), p < 0.001 for STR; 2.68(1.27–5.66), p = 0.010 for MIwoCR in the whole sample [HR: 16.58(6.70–40.98) p < 0.001 for HipFx; 7.35(3.01–17.93) p < 0.001 for STR, in men].

Conclusions

HipFx markedly impacts hospital care, and causes high in-hospital and long-term all-cause mortality, comparable to the two commonest non-tumor causes of death.
Appendix
Available only for authorised users
Literature
1.
go back to reference M.J. Prince, F. Wu, Y. Guo et al. The burden of disease in older people and implications for the health policy and practice. Lancet 385, 549–562 (2015)CrossRefPubMed M.J. Prince, F. Wu, Y. Guo et al. The burden of disease in older people and implications for the health policy and practice. Lancet 385, 549–562 (2015)CrossRefPubMed
2.
go back to reference P. Piscitelli, M. Feola, C. Rao et al. Ten years of hip fractures in Italy: for the first time a decreasing trend in elderly women. World J. Orthop. 5, 386–391 (2014)CrossRefPubMedPubMedCentral P. Piscitelli, M. Feola, C. Rao et al. Ten years of hip fractures in Italy: for the first time a decreasing trend in elderly women. World J. Orthop. 5, 386–391 (2014)CrossRefPubMedPubMedCentral
3.
go back to reference S.R. Cummings, L.J. Melton III, Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761–1767 (2002)CrossRefPubMed S.R. Cummings, L.J. Melton III, Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761–1767 (2002)CrossRefPubMed
4.
5.
go back to reference C. Cooper, Z.A. Cole, C.R. Holroyd et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos. Int. 22, 1277–1288 (2011)CrossRefPubMedPubMedCentral C. Cooper, Z.A. Cole, C.R. Holroyd et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos. Int. 22, 1277–1288 (2011)CrossRefPubMedPubMedCentral
6.
go back to reference P. Piscitelli, F. Gimigliano, S. Gatto et al. Hip fractures in Italy: 2000-2005 extension study. Osteoporos. Int. 21, 1323–1330 (2010)CrossRefPubMed P. Piscitelli, F. Gimigliano, S. Gatto et al. Hip fractures in Italy: 2000-2005 extension study. Osteoporos. Int. 21, 1323–1330 (2010)CrossRefPubMed
7.
go back to reference F. Nilson, S. Moniruzzaman, J. Gustavsson, R. Andersson, Trends in hip fracture incidence rates among the elderly in Sweden 1987-2009. J. Public Health 35, 125–131 (2012)CrossRef F. Nilson, S. Moniruzzaman, J. Gustavsson, R. Andersson, Trends in hip fracture incidence rates among the elderly in Sweden 1987-2009. J. Public Health 35, 125–131 (2012)CrossRef
8.
go back to reference N. Williams, B.M. Hardy, S. Tarrant, et al. Changes in hip fracture incidence, mortality and length of stay over the last decade in an Australian major trauma centre. Arch. Osteoporos. (2013) https://doi.org/10.1007/s11657-013-0150-3-8: 150 N. Williams, B.M. Hardy, S. Tarrant, et al. Changes in hip fracture incidence, mortality and length of stay over the last decade in an Australian major trauma centre. Arch. Osteoporos. (2013) https://​doi.​org/​10.​1007/​s11657-013-0150-3-8: 150
9.
go back to reference S. Mundi, B. Pindiprolu, N. Simunovic, M. Bhandari, Similar mortality rates in hip fracture patients over the past 31 years. Acta. Orthop. 85, 54–59 (2014)CrossRefPubMedPubMedCentral S. Mundi, B. Pindiprolu, N. Simunovic, M. Bhandari, Similar mortality rates in hip fracture patients over the past 31 years. Acta. Orthop. 85, 54–59 (2014)CrossRefPubMedPubMedCentral
10.
go back to reference S. Morin, L.M. Lix, M. Azimaee, C. Metge, P. Caetano, W.D. Leslie, Mortality rates after incident non traumatic fractures in older men and women. Osteoporos. Int. 22, 2439–2448 (2001)CrossRef S. Morin, L.M. Lix, M. Azimaee, C. Metge, P. Caetano, W.D. Leslie, Mortality rates after incident non traumatic fractures in older men and women. Osteoporos. Int. 22, 2439–2448 (2001)CrossRef
11.
go back to reference L.J. Melton III, S.J. Achenbach, E.J. Atkinson, T.M. Therneau, S. Amin, Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos. Int. 24, 1689–1696 (2013)CrossRefPubMed L.J. Melton III, S.J. Achenbach, E.J. Atkinson, T.M. Therneau, S. Amin, Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos. Int. 24, 1689–1696 (2013)CrossRefPubMed
12.
go back to reference B. Abrahamsen, T. van Staa, R. Ariely, M. Olson, C. Cooper, Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos. Int. 20, 1633–1650 (2009)CrossRefPubMed B. Abrahamsen, T. van Staa, R. Ariely, M. Olson, C. Cooper, Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos. Int. 20, 1633–1650 (2009)CrossRefPubMed
13.
go back to reference J.R. Center, T.V. Nguyen, D. Schneider, P.N. Sambrook, J.A. Eisman, Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353, 878–882 (1999)CrossRefPubMed J.R. Center, T.V. Nguyen, D. Schneider, P.N. Sambrook, J.A. Eisman, Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353, 878–882 (1999)CrossRefPubMed
14.
go back to reference G. Ioannidis, A. Papaioannou, W.M. Hopman et al. Relation between fractures and mortality: Results from the Canadian multicentre osteoporosis study. CMAJ 181, 265–271 (2009)CrossRefPubMedPubMedCentral G. Ioannidis, A. Papaioannou, W.M. Hopman et al. Relation between fractures and mortality: Results from the Canadian multicentre osteoporosis study. CMAJ 181, 265–271 (2009)CrossRefPubMedPubMedCentral
15.
go back to reference L. Forsén, A.J. Søgaard, H.E. Meyer, T.H. Edna, B. Kopjar, Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos. Int. 10, 73–78 (1999)CrossRefPubMed L. Forsén, A.J. Søgaard, H.E. Meyer, T.H. Edna, B. Kopjar, Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos. Int. 10, 73–78 (1999)CrossRefPubMed
16.
go back to reference M. Tsuboi, Y. Hasegawa, S. Suzuki, H. Wingstrand, K.G. Thorngren, Mortality ad mobility after hip fracture in Japan. J. Bone Joint Surg. 89, 461–466 (2007). BCrossRef M. Tsuboi, Y. Hasegawa, S. Suzuki, H. Wingstrand, K.G. Thorngren, Mortality ad mobility after hip fracture in Japan. J. Bone Joint Surg. 89, 461–466 (2007). BCrossRef
17.
go back to reference P. Vestergaard, L. Rejnmark, L. Mosekilde, Increased mortality in patients with a hip fracture-effect of premorbid conditions and post-fracture complications. Osteoporos. Int. 18, 1583–1593 (2007)CrossRefPubMed P. Vestergaard, L. Rejnmark, L. Mosekilde, Increased mortality in patients with a hip fracture-effect of premorbid conditions and post-fracture complications. Osteoporos. Int. 18, 1583–1593 (2007)CrossRefPubMed
18.
go back to reference A.Y.J. Lee, J. Tan, S.M.C. Fook-Chong, N.N. Lo, T.S. Howe, Five-year outcome of individuals with hip fracture admitted to a Singapore hospital: quality of life and survival rates after treatment. J. Am. Geriatr. 60, 994–996 (2012)CrossRef A.Y.J. Lee, J. Tan, S.M.C. Fook-Chong, N.N. Lo, T.S. Howe, Five-year outcome of individuals with hip fracture admitted to a Singapore hospital: quality of life and survival rates after treatment. J. Am. Geriatr. 60, 994–996 (2012)CrossRef
19.
go back to reference P. Haentjens, J. Magaziner, C.S. Colón-Emeric et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann. Intern. Med. 152, 380–390 (2010)CrossRefPubMedPubMedCentral P. Haentjens, J. Magaziner, C.S. Colón-Emeric et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann. Intern. Med. 152, 380–390 (2010)CrossRefPubMedPubMedCentral
20.
go back to reference V.L. Feigin, M.H. Farouzanfar, R. Krishnamurthi et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 383, 245–255 (2014)CrossRefPubMedPubMedCentral V.L. Feigin, M.H. Farouzanfar, R. Krishnamurthi et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 383, 245–255 (2014)CrossRefPubMedPubMedCentral
21.
go back to reference R. Carandang, S. Seshadri, A. Beiser et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296, 2939–2946 (2006)CrossRefPubMed R. Carandang, S. Seshadri, A. Beiser et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296, 2939–2946 (2006)CrossRefPubMed
22.
go back to reference M.C. Fang, M.C. Perraillon, K. Ghosh, D.M. Cutler, A.B. Rosen, Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am. J. Med. 127, 608–615 (2014)CrossRefPubMedPubMedCentral M.C. Fang, M.C. Perraillon, K. Ghosh, D.M. Cutler, A.B. Rosen, Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. Am. J. Med. 127, 608–615 (2014)CrossRefPubMedPubMedCentral
23.
go back to reference E.S. Ford, U.A. Ajani, J.B. Croft et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356, 2388–2398 (2007)CrossRefPubMed E.S. Ford, U.A. Ajani, J.B. Croft et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356, 2388–2398 (2007)CrossRefPubMed
24.
go back to reference S. Setoguchi, R.J. Glynn, J. Avorn, M.A. Mittleman, R. Levin, W.C. Winkelmeyer, Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge. J. Am. Coll. Cardiol. 51, 1247–1254 (2008)CrossRefPubMed S. Setoguchi, R.J. Glynn, J. Avorn, M.A. Mittleman, R. Levin, W.C. Winkelmeyer, Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge. J. Am. Coll. Cardiol. 51, 1247–1254 (2008)CrossRefPubMed
25.
go back to reference S.T. Nauta, J. Deckers, K.M. Akkerhuis, R.T. van Domburg, Short- and long-term mortality after myocardial infarction in patients with and without diabetes. Diabetes Care 35, 2043–2047 (2012)CrossRefPubMedPubMedCentral S.T. Nauta, J. Deckers, K.M. Akkerhuis, R.T. van Domburg, Short- and long-term mortality after myocardial infarction in patients with and without diabetes. Diabetes Care 35, 2043–2047 (2012)CrossRefPubMedPubMedCentral
27.
go back to reference H.M. Krumholz, S.-L.T. Normand, Y. Wang, Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011. Circulation 130, 966–975 (2014)CrossRefPubMedPubMedCentral H.M. Krumholz, S.-L.T. Normand, Y. Wang, Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011. Circulation 130, 966–975 (2014)CrossRefPubMedPubMedCentral
28.
go back to reference E.S. Spatz, A.L. Beckman, Y. Wang, H.M. Krumholz, Geographic variation in trends and disparities in acute myocardial infarction hospitalization and mortality by income levels, 1999-2013. JAMA Cardiol. 1, 255–265 (2016)CrossRefPubMedPubMedCentral E.S. Spatz, A.L. Beckman, Y. Wang, H.M. Krumholz, Geographic variation in trends and disparities in acute myocardial infarction hospitalization and mortality by income levels, 1999-2013. JAMA Cardiol. 1, 255–265 (2016)CrossRefPubMedPubMedCentral
29.
go back to reference I.R. Dégano, V. Salomaa, G. Veronesi et al. Twenty-five year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart 101, 1413–1421 (2015)CrossRefPubMed I.R. Dégano, V. Salomaa, G. Veronesi et al. Twenty-five year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart 101, 1413–1421 (2015)CrossRefPubMed
30.
go back to reference J.A. Kanis, A. Oden, O. Johnell, C. De Laet, B. Jonsson, A.K. Oglesby, The components of excess mortality after hip fracture. Bone 32, 468–473 (2003)CrossRefPubMed J.A. Kanis, A. Oden, O. Johnell, C. De Laet, B. Jonsson, A.K. Oglesby, The components of excess mortality after hip fracture. Bone 32, 468–473 (2003)CrossRefPubMed
31.
go back to reference M. von Friesendorff, F.E. McGuigan, A. Wizert et al. Hip fractures, mortality risk, and cause of death over two decades. Osteoporos. Int. 27, 2945–2953 (2016)CrossRef M. von Friesendorff, F.E. McGuigan, A. Wizert et al. Hip fractures, mortality risk, and cause of death over two decades. Osteoporos. Int. 27, 2945–2953 (2016)CrossRef
32.
go back to reference H.X. Jiang, S.R. Majumdar, D.A. Dick et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J. Bone. Miner. Res. 20, 494–500 (2005)CrossRefPubMed H.X. Jiang, S.R. Majumdar, D.A. Dick et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J. Bone. Miner. Res. 20, 494–500 (2005)CrossRefPubMed
33.
go back to reference V. Carnevale, L. Nieddu, E. Romagnoli et al. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric nationwide Italian Survey. Osteoporos. Int. 17, 478–483 (2006)CrossRefPubMed V. Carnevale, L. Nieddu, E. Romagnoli et al. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric nationwide Italian Survey. Osteoporos. Int. 17, 478–483 (2006)CrossRefPubMed
34.
go back to reference L. Luan, R. Li, Z. Wang et al. Stroke increases the risk of hip fracture: a systematic review and meta-analysis. Osteoporos. Int. 27, 3149–3154 (2016)CrossRefPubMed L. Luan, R. Li, Z. Wang et al. Stroke increases the risk of hip fracture: a systematic review and meta-analysis. Osteoporos. Int. 27, 3149–3154 (2016)CrossRefPubMed
35.
go back to reference J.H. Kang, S.-D. Chung, S. Xirasagar, F.-S. Jaw, H.-C. Lin, Increased risk of stroke in the year after a hip fracture. A population-based follow-up study. Stroke 42, 336–341 (2011)CrossRefPubMed J.H. Kang, S.-D. Chung, S. Xirasagar, F.-S. Jaw, H.-C. Lin, Increased risk of stroke in the year after a hip fracture. A population-based follow-up study. Stroke 42, 336–341 (2011)CrossRefPubMed
36.
go back to reference C.H. Tsai, C.-L. Liu, H.-C. Hsu, W.-S. Chung, Increased risk of stroke among hip fracture patients: a nationwide cohort study. Osteoporos. Int. 26, 645–652 (2015)CrossRefPubMed C.H. Tsai, C.-L. Liu, H.-C. Hsu, W.-S. Chung, Increased risk of stroke among hip fracture patients: a nationwide cohort study. Osteoporos. Int. 26, 645–652 (2015)CrossRefPubMed
37.
go back to reference C.-H. Chiang, C.-J. Liu, P.-J. Chen et al. Hip fracture and risk of acute myocardial infarction: a nationwide study. J. Bone Miner. Res. 28, 404–411 (2013)CrossRefPubMed C.-H. Chiang, C.-J. Liu, P.-J. Chen et al. Hip fracture and risk of acute myocardial infarction: a nationwide study. J. Bone Miner. Res. 28, 404–411 (2013)CrossRefPubMed
38.
go back to reference L’evoluzione della mortalità per causa: le prime 25 cause di morte. http://www.istat.it/it/files/2017/05/Report-cause-di-morte-2003-2014. Accessed 09 May 2017 L’evoluzione della mortalità per causa: le prime 25 cause di morte. http://​www.​istat.​it/​it/​files/​2017/​05/​Report-cause-di-morte-2003-2014.​ Accessed 09 May 2017
39.
go back to reference I.D. Cameron, J.S. Chen, L.M. March et al. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J. Bone Miner. Res. 25, 866–872 (2010)PubMed I.D. Cameron, J.S. Chen, L.M. March et al. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J. Bone Miner. Res. 25, 866–872 (2010)PubMed
40.
go back to reference J.P. Holm, L. Hyldstrup, J.B. Jensen, Time trends in osteoporosis risk factor profile: a comparative analysis of risk factors, comorbidities, and medications over twelve years. Endocrine 54, 241–255 (2016)CrossRefPubMed J.P. Holm, L. Hyldstrup, J.B. Jensen, Time trends in osteoporosis risk factor profile: a comparative analysis of risk factors, comorbidities, and medications over twelve years. Endocrine 54, 241–255 (2016)CrossRefPubMed
Metadata
Title
Incidence and all-cause mortality for hip fracture in comparison to stroke, and myocardial infarction: a fifteen years population-based longitudinal study
Authors
Vincenzo Carnevale
Andrea Fontana
Alfredo Scillitani
Roberto Sinisi
Elisabetta Romagnoli
Massimiliano Copetti
Publication date
01-11-2017
Publisher
Springer US
Published in
Endocrine / Issue 2/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1423-1

Other articles of this Issue 2/2017

Endocrine 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.